O Yoshida
About
In The Last Decade
O Yoshida
32 papers receiving 417 citations
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 173
- Molecular Biology 151
- Oncology 123
- Surgery 80
- Cancer Research 74
Countries citing papers authored by O Yoshida
This map shows the geographic impact of O Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Yoshida more than expected).
Fields of papers citing papers by O Yoshida
This network shows the impact of papers produced by O Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Yoshida. The network helps show where O Yoshida may publish in the future.
Co-authorship network of co-authors of O Yoshida
This figure shows the co-authorship network connecting the top 25 collaborators of O Yoshida. A scholar is included among the top collaborators of O Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Yoshida. O Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | Antiviral drugs for treatment of chronic hepatitis B virus infection: what is expected and what can be achieved in developing countries. | 1 |
| 3 | [A study on parameters to predict tumor volume for stage T1c prostate cancers of Gleason score 6 or less]. | 1 |
| 4 | 32 | |
| 5 | [Gene therapy by in vivo interferon-gamma gene transfer to murine bladder tumor]. | 4 |
| 6 | 2 | |
| 7 | 18 | |
| 8 | [Activation of imprinted genes in human carcinogenesis]. | 1 |
| 9 | [E-cadherin expression and histopathological features in renal cell carcinomas]. | 3 |
| 10 | 2 | |
| 11 | [Study of clinical usefulness of an antiandrogen, TZP-4238, as a drug for treatment of benign prostatic hypertrophy--its influence on sexual function]. | 0 |
| 12 | 67 | |
| 13 | 40 | |
| 14 | 7 | |
| 15 | [A comparison of the quality of life of prostatic cancer patients under slow releasing LH-RH analogue (TAP-144SR Depot) treatment or synthetic estrogen treatment]. | 2 |
| 16 | [Leiomyosarcoma of the prostate: a case report]. | 1 |
| 17 | [Results of the multidisciplinary treatment of invasive bladder cancer]. | 3 |
| 18 | 14 | |
| 19 | [Study on heterotransplantation of malignant urogenital tumors in nude mice: results of transplantation and the characteristics of the explants]. | 5 |
| 20 | [Ultrasound-guided renal cyst puncture and 95% ethanol injection. Part 1: Estimation of ethanol levels in the blood and urine following 95% ethanol injection]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.